3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
106
Lung Neoplasms
41
Neoplasms
13
Neoplasm Metastasis
11
Colorectal Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Pancreatic Neoplasms
6
Carcinoma
6
Mesothelioma, Malignant
5
Mesothelioma
5
Ovarian Neoplasms
4
Meningeal Carcinomatosis
4
Melanoma
4
Colonic Neoplasms
4
Advanced Solid Tumors
4
Rectal Neoplasms
3
Neoplasms by Site
3
Lung Diseases
3
Carcinoma, Bronchogenic
3
Adenocarcinoma of Lung
3
Adenocarcinoma
3
Uterine Cervical Neoplasms
2
Thoracic Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Respiratory Tract Neoplasms
2
Respiratory Tract Diseases
2
Non-squamous Non-small Cell Lung Cancer
2
Non-Small Cell Lung Cancer Metastatic
2
Non Small Cell Lung Carcinoma NSCLC
2
Interventions
Cisplatin
14
Paclitaxel
12
pembrolizumab
9
Fluorouracil
7
Radiotherapy
6
Irinotecan
5
Esophagectomy
5
tislelizumab
4
Oxaliplatin
4
Leucovorin
4
Drug Therapy
4
Carboplatin
4
toripalimab
3
Levoleucovorin
3
Docetaxel
3
Capecitabine
3
camrelizumab
2
Taxes
2
Radiation
2
Nivolumab
2
Injections
2
130-nm albumin-bound paclitaxel
2
spartalizumab
1
sintilimab
1
palbociclib
1
nimotuzumab
1
nazartinib
1
lenvatinib
1
ivarmacitinib
1
futibatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Pemetrexed
×
90 days
×
Clear all
No trials found.